Understanding the genetic basis of schizophrenia may lead to earlier identification of the illness and improved treatment. This workshop will take a close look at recent advances in genetics, the prodromal phase of the disease, and efforts to identify the illness early and intervene before development of a psychotic episode. We will also look at the pharmacologic treatment of schizophrenia and metabolic side effects of that treatment, as well as efforts to understand and improve real-world functioning among people with schizophrenia.

• David Braff, M.D., professor of psychiatry, University of California – San Diego, La Jolla, CA
• Jonathon Meyer, M.D., assistant professor, University of California – San Diego, La Jolla, CA
• Greg Light, M.D., assistant professor of psychiatry, University of California – San Diego, La Jolla, CA
• Moderator: Kristin Cadenhead, M.D., associate professor of psychiatry, University of California – San Diego, La Jolla, CA